RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
221 hedge funds and large institutions have $4.19B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 72 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
53% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 47
4% less call options, than puts
Call options by funds: $220M | Put options by funds: $230M
Holders
221
Holding in Top 10
17
Calls
$220M
Puts
$230M
Top Buyers
| 1 | +$74.1M | |
| 2 | +$74.1M | |
| 3 | +$62M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$50.3M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$42.5M |
Top Sellers
| 1 | -$180M | |
| 2 | -$74.6M | |
| 3 | -$28.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$26.2M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$22.7M |